London, UK — The Allergy Centre of Excellence is proud to announce its pioneering peanut allergy treatment programme, offering advanced oral immunotherapy (OIT) for children across the United Kingdom. Peanut allergy, affecting around 2% of UK children and often persisting beyond early childhood, is one of the most common causes of severe food‑related anaphylaxis. Traditionally, strict avoidance has been the only management option. However, thanks to recent advances in allergy science, families now have access to life‑changing treatment that reduces the risk of accidental reactions and improves quality of life.

Peanut allergy is a potentially life‑threatening condition that typically develops early in life and rarely resolves after the age of four. Until recent years, the standard of care in the UK was limited to allergen avoidance, education on recognising allergic reactions, and emergency management plans. With the introduction of oral immunotherapy, this landscape is shifting, giving patients and their families new hope.

What Is Oral Immunotherapy (OIT)?

Oral immunotherapy is a clinically supervised treatment that involves administering gradually increasing, carefully measured doses of peanut protein to children with a confirmed peanut allergy. Over time, this method can increase the body’s tolerance to peanut protein, meaning that higher amounts can be consumed without triggering severe allergic reactions. Although this process does not constitute a cure, it significantly raises the threshold at which reactions occur, reducing the likelihood of adverse responses to accidental exposures.

Unlike traditional avoidance strategies, OIT works by gently training the immune system. Treatment involves an initial phase of very low doses under close medical supervision, followed by a structured up‑dosing period and a long‑term maintenance phase. Throughout this journey, patients and their families receive ongoing guidance, support, and monitoring from specialist clinicians.

Licensed Treatment and Expert Care in the UK

The Allergy Centre of Excellence is the largest provider of Palforzia — the first licensed peanut oral immunotherapy product — in Europe. Palforzia, approved by UK and European regulators, is used as part of a controlled treatment protocol designed to increase tolerance levels safely. The centre’s world‑class team of allergists and paediatric specialists brings unparalleled expertise to delivering this treatment, ensuring every child receives personalised care tailored to their specific needs.

Comprehensive Support for Families

Understanding that peanut allergy affects both children and their families emotionally and practically, the Allergy Centre of Excellence offers comprehensive support throughout the treatment process. From the initial assessment and diagnostic testing to ongoing supervision and follow‑up care, parents are educated on recognising reactions and managing doses safely. Emergency medication guidance, nutritional advice, and clear communication are integral parts of the programme.

Not a Cure, But a Transformative Option

It is important to note that oral immunotherapy is not a cure for peanut allergy. Regular intake of a maintenance dose is essential to sustaining desensitisation; if treatment is discontinued, sensitivity typically returns. Nevertheless, for many families, the opportunity to reduce the risk of severe reactions brings newfound confidence and freedom in everyday life.

Accessible and Patient‑Centred

The centre offers tailored treatment plans to suit each child’s clinical profile, with clear pricing and flexible options. Self‑referral pathways are available, allowing families to access expert care directly, without the need for a GP referral. All programmes are delivered in state‑of‑the‑art facilities with the highest standards of safety and clinical governance.

About the Allergy Centre of Excellence

Based in London, the Allergy Centre of Excellence specialises in cutting‑edge allergy diagnostics and treatments, including oral immunotherapy for peanut and other food allergies. Supported by internationally recognised paediatric allergy professors and clinicians, the centre is committed to improving the lives of children with allergies through evidence‑based, personalised care.

For further information, visit https://allergycentre.co.uk/treatments/peanut/